Cannabis use while Breastfeeding
Medically reviewed on May 1, 2018.
Cannabis Levels and Effects while Breastfeeding
Summary of Use during Lactation
Although published data are limited, it appears that main psychoactive component of cannabis, tetrahydrocannabinol (THC), is excreted into breastmilk in small quantities. Concern has been expressed regarding cannabis's possible effects on neurotransmitters, nervous system development and endocannabinoid-related functions. One long-term study found that daily or near daily use might retard the breastfed infant's motor development, but not growth or intellectual development. This and another study found that occasional maternal cannabis use during breastfeeding did not have any discernable effects on breastfed infants, but the studies were inadequate to rule out all long-term harm. Although cannabis can affect serum prolactin variably, it appears not to adversely affect the duration of lactation. Other factors to consider are the possibility of positive urine tests in breastfed infants, which might have legal implications, and the possibility of other harmful contaminants in street drugs. Health professionals' opinions on the acceptability of breastfeeding by cannabis-using mothers varies considerably.
Cannabis use should be minimized or avoided by nursing mothers because it may impair their judgment and child care abilities. Some evidence indicates that paternal cannabis use increases the risk of sudden infant death syndrome in breastfed infants. Cannabis should not be smoked by anyone in the vicinity of infants because the infants may be exposed by inhaling the smoke. Because breastfeeding can mitigate some of the effects of smoking and little evidence of serious infant harm has been seen, it appears preferable to encourage mothers who use cannabis to continue breastfeeding and reducing or abstaining from cannabis use while minimizing infant exposure to the smoke.
The main psychoactive component of cannabis is delta-9-tetrahydrocannabinol (THC), although it also contains other active compounds. THC is very fat soluble and persistent in the body fat of users and slowly released over days to weeks, depending on the extent of use.
Maternal Levels. Two women who smoked marijuana daily while nursing had their randomly collected milk analyzed. One mother who reported smoking marijuana once daily had a milk tetrahydrocannabinol concentration of 105 mcg/L; other metabolites were absent. The second mother who reported smoking marijuana 7 to 8 times daily had a milk concentration of 340 mcg/L; the metabolite 11-hydroxy-THC was found in a concentration of 4 mcg/L and 9-carboxy-THC was absent. A milk sample that was collected 1 hour after smoking marijuana contained 60.3 mcg/L of THC, 1.1 mcg/L of 11-hydroxy-THC and 1.6 mcg/L of 9-carboxy-THC. One source used data in this case to estimate that the infant receives about 0.8% of the maternal weight-adjusted dosage. However, a poorly characterized assay was used that might not be accurate and the portion of milk (i.e., foremilk versus hindmilk) that was collected by the mothers was not stated. This is important because of the high fat solubility of THC.
A woman who admitted to smoking cannabis (amount not stated) donated milk for analysis at an unknown time after the previous use. THC was present in a concentration of 86 mcg/L and 11-hydroxy-THC was present in a concentration of 5 mcg/L; 11-nor-carboxy-9-tetrahydrocannabinol was not detected.
Analysis of 19 breastmilk samples in women who declared prior use of cannabis found a THC concentration of 20 mcg/L in the breastmilk of one woman. Another mother who did not declare a history of drug abuse had a THC concentration of 31 mcg/L; cannabidiol was also detected, but not quantified in her milk.
Eight exclusively nursing women who were 3 to 5 months postpartum and reported regular cannabis smoking were studied. After 24 hours of abstinence, each smoked a 100 mg of a standardized cannabis containing 23.18% THC. The product was smoked over 10 to 20 minutes from a glass pipe until it was fully consumed. Milk was pumped before smoking and at 20 minutes, 1, 2 and 4 hours after inhalation. THC and its metabolites, 11-OH-delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol were measured in the milk samples. Six of the women had baseline THC concentrations of <2 mcg/L; the other two had 5.8 and 15.8 mcg/L of THC in their milk at baseline. The average THC concentration in breastmilk was 53.5 mcg/L (range 12.2 to 420.3 mcg/L), and the average peak THC concentration was 94 mcg/L at 1 hour after inhalation. The metabolites were not measurable (<0.097 mcg/L). The estimated daily THC intake for the infant was 8 mcg/kg, which corresponded to 2.5% (range 0.4 to 8.7%) of the weight-adjusted maternal dosage.
Infant Levels. The urine of 2 breastfed infants whose mothers smoked marijuana found none of the 9-carboxy-THC metabolite. One mother reported smoking marijuana once daily and the other reported smoking marijuana 7 to 8 times daily. Analysis of the feces of the latter mother's infant revealed a higher proportion of metabolites than THC, indicating that THC was probably absorbed from the milk, metabolized by the infant, and excreted in feces.
Effects in Breastfed Infants
Twenty-seven mothers reported smoking marijuana during breastfeeding. Twelve of them smoked once a month or less, 9 smoked weekly, and 6 smoked daily. Six of their infants were compared at 1 year of age to the infants of mothers who did not smoke marijuana during pregnancy or breastfeeding. No differences were found in growth, or on mental and motor development.
Sixty-eight infants whose mothers reported smoking marijuana during breastfeeding were compared to 68 matched control infants whose mothers did not smoke marijuana. The duration of breastfeeding varied, but the majority of infants were breastfeed for 3 months and received less than 16 fluid ounces of formula daily. Motor development of the marijuana-exposed infants was slightly reduced in a dose-dependent (i.e., number of reported joints per week) manner at 1 year of age, especially among those who reported smoking marijuana on more than 15 days/month during the first month of lactation. No effect was found on mental development.
A small, case-control study found that paternal marijuana smoking postpartum increased the risk of sudden infant death syndrome. In this study, too few nursing mothers smoked marijuana to form any conclusion.
A study of women taking buprenorphine for opiate substitution during pregnancy and lactation found that 4 of the women were also using cannabis as evidenced by positive urine screens for THC between 29 and 56 days postpartum. One was also taking unprescribed benzodiazepines. One infant was exclusively breastfed and the other 3 were mostly breastfeeding with partial supplementation. Infants had no apparent drug-related adverse effects and showed satisfactory developmental progress.
A 7-month-old previously healthy, unvaccinated, breastfed (extent not stated) boy presented to the ED with increasing lethargy for 6 hours and nonbilious, nonbloody vomiting for 2 hours and a 1-day history of watery diarrhea, cough and congestion. The infant had reportedly fallen 8 inches from a mattress to the floor on the previous evening and breastfed more frequently afterwards. The mother reported that both she and her partner used medical cannabis legally and the infant had a positive urine drug screen for cannabis. Cannabis in breastmilk was a possible contributing factor to the infant's lethargy, but possible direct ingestion could not be ruled out.
Effects on Lactation and Breastmilk
Acute one-time marijuana smoking suppresses serum concentrations of luteinizing hormone and prolactin in nonpregnant, nonlactating women. The effects of long-term use is unclear, with some studies finding no effect on serum prolactin. However, hyperprolactinemia has been reported in some chronic cannabis users, and galactorrhea and hyperprolactinemia were reported in a woman who smoked marijuana for over 1 year. The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Of 258 mothers who reported smoking marijuana during pregnancy, 27 who had smoked marijuana during breastfeeding were followed-up at 1 year. No difference was found in the age of weaning between these mothers and 35 who reported not smoking marijuana during pregnancy or breastfeeding.
Colorado legalized medical cannabis in 2001 and recreational cannabis in 2012. A cross-sectional survey conducted in Colorado in 2014 and 2015 found that both prenatal and postnatal cannabis use were associated with a shorter duration of breastfeeding. Among women who reported using cannabis during pregnancy, 64% breastfed for 9 or more weeks compared with 78% of women who did not use cannabis during pregnancy. Among women who reported postpartum cannabis use, 58% breastfed for 9 weeks or more weeks compared with 79% of women who did not use cannabis postpartum. Both differences were statistically significant. A study using a database of 9013 postpartum women found that those who reported using marijuana were more likely to smoke cigarettes, experience postpartum depressive symptoms, and breastfeed for less than 8 weeks. Tobacco smoking is known to decrease the duration of breastfeeding, so the effect of marijuana is not clear.
1. Schuel H, Burkman LJ, Lippes J et al. N-acylethanolamines in human reproductive fluids. Chem Phys Lipids. 2002;121:211-27. PMID: 12505702
2. Fernandez-Ruiz J, Gomez M, Hernandez M et al. Cannabinoids and gene expression during brain development. Neurotox Res. 2004;6:389-401. PMID: 15545023
3. Astley SJ, Little RE. Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol. 1990;12:161-8. PMID: 2333069
4. Tennes K, Avitable N, Blackard C et al. Marijuana: prenatal and postnatal exposure in the human. NIDA Res Monogr. 1985;59:48-60. PMID: 3929132
5. Jansson LM, Bunik M, Bogen DL. Lactation and the marijuana-using mother. Breastfeed Med. 2015;10:342-3. PMID: 26121013
6. Marinelli KA, Reece-Stremtan S. Response to Jansson et al. Breastfeed Med. 2015;10:344-5. PMID: 26121124
7. Bergeria CL, Heil SH. Surveying lactation professionals regarding marijuana use and breastfeeding. Breastfeed Med. 2015;10:377-80. PMID: 26252053
8. Hill M, Reed K. Pregnancy, breast-feeding, and marijuana: A review article. Obstet Gynecol Surv. 2013;68:710-8. PMID: 25101905
9. Reece-Stremtan S, Marinelli KA. ABM Clinical Protocol #21: Guidelines for Breastfeeding and Substance Use or Substance Use Disorder, Revised 2015. Breastfeed Med. 2015;10:135-41. PMID: 25836677
10. Metz TD, Stickrath EH. Marijuana use in pregnancy and lactation: A review of the evidence. Am J Obstet Gynecol. 2015;213:761-78. PMID: 25986032
11. Perez-Reyes M, Wall ME. Presence of delta 9-tetrahydrocannabinol in human milk. N Engl J Med. 1982;307:819-20. Letter. PMID: 6287261
12. Bennett PN, ed. Drugs and human lactation, 2nd ed. Amsterdam. Elsevier. 1996.
13. Marchei E, Escuder D, Pallas CR et al. Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2011. PMID: 21330091
14. Silveira GD, Loddi S, De Oliveira CDR et al. Headspace solid-phase microextraction and gas chromatography-mass spectrometry for determination of cannabinoids in human breast milk. Forensic Toxicol. 2017;35:125-32. DOI: doi:10.1007/s11419-016-0346-5
15. Baker T, Datta P, Rewers-Felkins K et al. Transfer of inhaled cannabis into human breast milk. Obstet Gynecol. 2018;131:783-8. PMID: 29630019
16. Klonoff-Cohen H, Lam-Kruglick P. Maternal and paternal recreational drug use and sudden infant death syndrome. Arch Pediatr Adolesc Med. 2001;155:765-70. PMID: 11434841
17. Ilett KF, Hackett LP, Gower S et al. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment. Breastfeed Med. 2012;7:269-74. PMID: 22011128
18. Thomas AA, Mazor S. Unintentional marijuana exposure presenting as altered mental status in the pediatric emergency department: A case series. J Emerg Med. 2017;53:e119-e123. PMID: 28987305
19. Mendelson JH, Mello NK, Ellingboe J et al. Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther. 1986;237:862-6. PMID: 3012072
20. Mendelson JH, Mello NK, Ellingboe J. Acute effects of marihuana smoking on prolactin levels on human females. J Pharmacol Exp Ther. 1985;232:220-2. PMID: 3965692
21. Murphy LL, Munoz RM, Adrian BA, Villanua MA. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis. 1998;5 (6 Pt B):432-46. PMID: 9974176
22. Block RI, Farinpour R, Schlechte JA. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend. 1991;28:121-8. PMID: 1935564
23. Brown TT, Dobs AS. Endocrine effects of marijuana. J Clin Pharmacol. 2002;42 (11 Suppl):90S-6S. PMID: 12412841
24. Ranganathan M, Braley G, Pittman B et al. The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology (Berl). 2009;203:737-44. PMID: 19083209
25. Olusi SO. Hyperprolactinaemia in patients with suspected cannabis-induced gynaecomastia. Lancet. 1980;1:255. PMID: 6101701
26. Harmon J, Aliapoulios MA. Gynecomastia in marihuana users. N Engl J Med. 1972;287:936. Letter. PMID: 5075561
27. Rizvi AA. Hyperprolactinemia and galactorrhea associated with marijuana use. Endocrinologist. 2006;16:308-10. DOI: doi:10.1097/01.ten.0000250184.10041.9d
28. Crume TL, Juhl AL, Brooks-Russell A et al. Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: The association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. J Pediatr. 2018. PMID: 29605394
29. Ko JY, Tong VT, Bombard JM et al. Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study. Drug Alcohol Depend. 2018;187:72-8. PMID: 29627409
CAS Registry Number
LactMed Record Number
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.